miRNA Tools and Services Market By Product and Services, By Technology, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

Description

List of Tables

The global miRNA tools and services market was valued $311.86 million in 2021 and expected to reach $1,822.15 million by 2031, with a CAGR of 19.3% from 2022 to 2031. After the process of transcription, the molecules that regulate gene expressions are microRNAs (miRNAs). MiRNAs are a type of non-coding RNA. MiRNAs have been found in a variety of organs and extracellularly in bio fluids such serum, plasma, saliva, and urine. Because miRNAs are highly stable in samples like FFPE, plasma, and serum, they can be used to generate biomarkers and clinical diagnostics. MicroRNA (miRNA) is a type of noncoding RNA with a length of 22nt that is responsible for RNA silencing and post-transcriptional regulation of gene expression in numerous cancer cells at the same time. Base-pairing with complementary sequences within mRNA molecules is how they work. They've recently been studied as novel therapeutic agents for treating a variety of illnesses, including cancer and infections.

Development of new product tools is one of the most important recent advancements in the miRNA market. Nano String Technologies Inc., for example, launched the GeoMx Digital Spatial Profiler in 2020, which allowed for highly-multiplexed spatial profiling of RNA and protein targets in a range of sample types, including FFPE tissue sections.

Recent advancements in microRNA applications, such as possible biomarkers in sophisticated diagnostics, have accelerated the development of new products and research in exploration of miRNA are all factors that drive the growth of miRNA tools and services market. The formation of massive amounts of public and private money is one of the primary factors contributing to market expansion. Advantages of miRNA sequencing over other technologies, increase in development of genomics products, and decline in the falling cost of sequencing are all driving this market forward. However, the inconvenient nature of microRNAs' development is exacerbated by their complexity and fragility. Furthermore, the market is expected to flourish by bioinformatics and technologically improved systems, such as Next-Generation Sequencing.

The miRNA tools and services market is segmented on the basis of product, technology, end user, and region. By product, the industry classified into research tools and services. The research tools segment is further segmented into kits, reagents, and other consumables, and services segment is fragmented into miRNA extraction services, quantification services, microarray services, sequencing services, functional studies services, and others. By technology the market is segregated into extraction tools, qrt-pcr, next-generation sequencing, microarray, functional analysis tools and others.

By end user, the market is classified into research & academic institutes, in vitro diagnostics, pharma & biotech companies, and contract research organizations s. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major key players that operate in the global miRNA tools and services market are Agilent Technologies, Bio-Rad laboratories, General Electrics, Integrated DNA Technologies, Koninklijike Philips N.V., Merck & Co., Omega Bio-Tek, Promega Corporation, Qiagen, and Thermo Fischer Scientific Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mirna tools and services market analysis from 2021 to 2031 to identify the prevailing miRNA tools and services market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the mirna tools and services market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global mirna tools and services market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product and Services

Research Tools
Services

By Technology

Extraction Tools
qRT-PCR
NGS
Microarray
Functional Analysis Tools
Others

By End User

Research and Academic Institutes
IVD, Pharma and Biotech Companies
CROs

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Agilent Technologies INC.
- Bio-Rad Laboratories, Inc.
- GeneCopoeia, Inc.
- Illumina, Inc.
- New England Biolabs
- Norgen Biotek Corp.
- Promega Corporation
- Qiagen N.V.
- Thermo Fisher Scientific inc
- General Electric Company

Product Code: A01773

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: MIRNA TOOLS AND SERVICES MARKET, BY PRODUCT AND SERVICES

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Research Tools
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Services
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country

CHAPTER 5: MIRNA TOOLS AND SERVICES MARKET, BY TECHNOLOGY

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Extraction Tools
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 qRT-PCR
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 NGS
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Microarray
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Functional Analysis Tools
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
5.7 Others
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market analysis by country

CHAPTER 6: MIRNA TOOLS AND SERVICES MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Research and Academic Institutes
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 IVD, Pharma and Biotech Companies
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 CROs
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: MIRNA TOOLS AND SERVICES MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product and Services
- 7.2.3 North America Market size and forecast, by Technology
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Product and Services
  - 7.2.5.1.2 Market size and forecast, by Technology
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Product and Services
  - 7.2.5.2.2 Market size and forecast, by Technology
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Product and Services
  - 7.2.5.3.2 Market size and forecast, by Technology
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product and Services
- 7.3.3 Europe Market size and forecast, by Technology
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Product and Services
  - 7.3.5.1.2 Market size and forecast, by Technology
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Product and Services
  - 7.3.5.2.2 Market size and forecast, by Technology
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 U.K.
  - 7.3.5.3.1 Market size and forecast, by Product and Services
  - 7.3.5.3.2 Market size and forecast, by Technology
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Product and Services
  - 7.3.5.4.2 Market size and forecast, by Technology
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Product and Services
  - 7.3.5.5.2 Market size and forecast, by Technology
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Product and Services
  - 7.3.5.6.2 Market size and forecast, by Technology
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product and Services
- 7.4.3 Asia-Pacific Market size and forecast, by Technology
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Product and Services
  - 7.4.5.1.2 Market size and forecast, by Technology
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Product and Services
  - 7.4.5.2.2 Market size and forecast, by Technology
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Market size and forecast, by Product and Services
  - 7.4.5.3.2 Market size and forecast, by Technology
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 India
  - 7.4.5.4.1 Market size and forecast, by Product and Services
  - 7.4.5.4.2 Market size and forecast, by Technology
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Product and Services
  - 7.4.5.5.2 Market size and forecast, by Technology
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Market size and forecast, by Product and Services
  - 7.4.5.6.2 Market size and forecast, by Technology
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product and Services
- 7.5.3 LAMEA Market size and forecast, by Technology
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Product and Services
  - 7.5.5.1.2 Market size and forecast, by Technology
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Product and Services
  - 7.5.5.2.2 Market size and forecast, by Technology
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Product and Services
  - 7.5.5.3.2 Market size and forecast, by Technology
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Product and Services
  - 7.5.5.4.2 Market size and forecast, by Technology
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Agilent Technologies INC.
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Bio-Rad Laboratories, Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 GeneCopoeia, Inc.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Illumina, Inc.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 New England Biolabs
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Norgen Biotek Corp.
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Promega Corporation
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Qiagen N.V.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Thermo Fisher Scientific inc
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 General Electric Company
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments